SingVax focuses on developing vaccines for diseases relevant to the Asia Pacific.
SingVax's product-focused approach ensures that its vaccines are developed in markets of high value and have strong commercialisation potential. SingVax taps upon its competitive advantages of expertise in vaccine development, established relations amongst the industry and academia, and experienced management, in order to develop improved and novel vaccines that address significant medical needs.
|
|
To fully develop its vaccines, SingVax uses a combination of in-house product development to achieve clinical proof-of-principle, collaborations for further clinical development and seeks partners for commercialisation. SingVax aims to be the partner of choice for vaccine companies, looking to access the Asia Pacific vaccine market. The company is actively looking for further products to expand its business.
Parties interested in knowing more about partnership or collaboration opportunities with SingVax may contact busdev@singvax.com
|
